4 Latest Advances in Epilepsy Treatment at Penn

Medical Breakthroughs from Penn Medicine

Contenuto fornito da ReachMD. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da ReachMD o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

8+ y ago

MP3•Pagina principale dell'episodio

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on January 10, 2024 12:11 (10M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Host: Jennifer Caudle, DO
Guest: Kathryn Davis, MD, MTR
Guest: Timothy Lucas, MD, PhD
According to the epilepsy foundation, epilepsy is the 4th most common neurological problem in the U.S. – only migraine, stroke and Alzheimer’s disease occur more frequently. The average incidence of epilepsy each year in the U. S is estimated at 150,000, or 48 for every 100,000 people. Host Dr. Jennifer Caudle talks with Doctors Kathryn Davis and Timothy Lucas about advances in treatment for epilepsy at Penn Medicine. Dr. Davis is Assistant Professor of Neurology and Medical Director of the Epilepsy Monitoring Unit and Epilepsy Surgical Program. Dr. Timothy Lucas is Assistant Professor of Neurosurgery, Surgical Director at the Penn Epilepsy Center, and Director of the Penn Center for Laser Neurosurgery.

114 episodi

#Science #Medicine #Breast Cancer #ReachMD #Health and Well-Being